Completed NA INTERVENTIONAL 2-arm NCT04508504

PENG Block for Arthroscopic Hip Surgery (PENG)

Pericapsular Nerve Group (PENG) Block for Arthroscopic Hip Surgery: A Randomized, Placebo-controlled Trial

Sponsor: University of Virginia

Conditions Hip Arthroscopy Postoperative Pain

Interventions Normal Saline Placebo block Preop PENG block Ropivacaine 0.5% Injectable Solution

Updated 6 times since 2020 Last updated: Mar 9, 2022 Started: Dec 1, 2020 Primary completion: Feb 1, 2022 Completion: Feb 8, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04508504, this NA trial focuses on Hip Arthroscopy and Postoperative Pain and remains completed. Sponsored by University of Virginia, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2021 — Apr 2022 [monthly]

Recruiting NA
Jan 2021 — Sep 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Sep 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Virginia

Data source: University of Virginia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charlottesville, United States